{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T05:49:29Z","timestamp":1772776169009,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T00:00:00Z","timestamp":1634947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T00:00:00Z","timestamp":1634947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006508","name":"Dhont Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006508","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2022,1,1]]},"DOI":"10.1038\/s41416-021-01592-7","type":"journal-article","created":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T09:02:49Z","timestamp":1634979769000},"page":"72-78","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Germline polymorphisms in genes maintaining the replication fork predict the efficacy of oxaliplatin and irinotecan in patients with metastatic colorectal cancer"],"prefix":"10.1038","volume":"126","author":[{"given":"Hiroyuki","family":"Arai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Millstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Battaglin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsuko","family":"Kawanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Jayachandran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivani","family":"Soni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Mancao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bodour","family":"Salhia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon M.","family":"Mumenthaler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5245-7841","authenticated-orcid":false,"given":"Aparna R.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2178-9568","authenticated-orcid":false,"given":"Heinz-Josef","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,23]]},"reference":[{"key":"1592_CR1","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nrm2858.","volume":"11","author":"S Negrini","year":"2010","unstructured":"Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability-an evolving hallmark of cancer. Nat Rev Mol Cell Biol. 2010;11:220\u20138. https:\/\/doi.org\/10.1038\/nrm2858.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1592_CR2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-pathol-012414-040424.","volume":"10","author":"M Macheret","year":"2015","unstructured":"Macheret M, Halazonetis TD. DNA replication stress as a hallmark of cancer. Annu Rev Pathol. 2015;10:425\u201348. https:\/\/doi.org\/10.1146\/annurev-pathol-012414-040424.","journal-title":"Annu Rev Pathol"},{"key":"1592_CR3","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41580-020-0257-5.","volume":"21","author":"M Berti","year":"2020","unstructured":"Berti M, Cortez D, Lopes M. The plasticity of DNA replication forks in response to clinically relevant genotoxic stress. Nat Rev Mol Cell Biol. 2020;21:633\u201351. https:\/\/doi.org\/10.1038\/s41580-020-0257-5.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1592_CR4","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nature05327.","volume":"444","author":"R Di Micco","year":"2006","unstructured":"Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature. 2006;444:638\u201342. https:\/\/doi.org\/10.1038\/nature05327.","journal-title":"Nature"},{"key":"1592_CR5","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nature03482.","volume":"434","author":"J Bartkova","year":"2005","unstructured":"Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature. 2005;434:864\u201370. https:\/\/doi.org\/10.1038\/nature03482.","journal-title":"Nature"},{"key":"1592_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.yexcr.2014.09.019.","volume":"329","author":"E Lecona","year":"2014","unstructured":"Lecona E, Fernandez-Capetillo O. Replication stress and cancer: it takes two to tango. Exp cell Res. 2014;329:26\u201334. https:\/\/doi.org\/10.1016\/j.yexcr.2014.09.019.","journal-title":"Exp cell Res"},{"key":"1592_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nsmb.2220.","volume":"19","author":"J Bartek","year":"2012","unstructured":"Bartek J, Mistrik M, Bartkova J. Thresholds of replication stress signaling in cancer development and treatment. Nat Struct Mol Biol. 2012;19:5\u20137. https:\/\/doi.org\/10.1038\/nsmb.2220.","journal-title":"Nat Struct Mol Biol"},{"key":"1592_CR8","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.molcel.2020.04.035.","volume":"78","author":"JM Cleary","year":"2020","unstructured":"Cleary JM, Aguirre AJ, Shapiro GI, D\u2019Andrea AD. Biomarker-guided development of DNA repair inhibitors. Mol Cell. 2020;78:1070\u201385. https:\/\/doi.org\/10.1016\/j.molcel.2020.04.035.","journal-title":"Mol Cell"},{"key":"1592_CR9","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/annonc\/mdz192.","volume":"30","author":"J Mateo","year":"2019","unstructured":"Mateo J, Lord CJ, Serra V, Tutt A, Balmana J, Castroviejo-Bermejo M, et al. A decade of clinical development of PARP inhibitors in perspective. Ann Oncol. 2019;30:1437\u201347. https:\/\/doi.org\/10.1093\/annonc\/mdz192.","journal-title":"Ann Oncol"},{"key":"1592_CR10","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.4161\/cc.21989.","volume":"11","author":"AR Leman","year":"2012","unstructured":"Leman AR, Noguchi E. Local and global functions of Timeless and Tipin in replication fork protection. Cell cycle. 2012;11:3945\u201355. https:\/\/doi.org\/10.4161\/cc.21989.","journal-title":"Cell cycle"},{"key":"1592_CR11","doi-asserted-by":"publisher","first-page":"16562","DOI":"10.1074\/jbc.M110.110304.","volume":"285","author":"MG Kemp","year":"2010","unstructured":"Kemp MG, Akan Z, Yilmaz S, Grillo M, Smith-Roe SL, Kang TH, et al. Tipin-replication protein A interaction mediates Chk1 phosphorylation by ATR in response to genotoxic stress. J Biol Chem. 2010;285:16562\u201371. https:\/\/doi.org\/10.1074\/jbc.M110.110304.","journal-title":"J Biol Chem"},{"key":"1592_CR12","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1073\/pnas.1222494110.","volume":"110","author":"WH Cho","year":"2013","unstructured":"Cho WH, Kang YH, An YY, Tappin I, Hurwitz J, Lee JK. Human Tim-Tipin complex affects the biochemical properties of the replicative DNA helicase and DNA polymerases. Proc Natl Acad Sci USA. 2013;110:2523\u20137. https:\/\/doi.org\/10.1073\/pnas.1222494110.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1592_CR13","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1101\/gad.1301205.","volume":"19","author":"TS Byun","year":"2005","unstructured":"Byun TS, Pacek M, Yee MC, Walter JC, Cimprich KA. Functional uncoupling of MCM helicase and DNA polymerase activities activates the ATR-dependent checkpoint. Genes Dev. 2005;19:1040\u201352. https:\/\/doi.org\/10.1101\/gad.1301205.","journal-title":"Genes Dev"},{"key":"1592_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3109\/10409238.2012.655374.","volume":"47","author":"A Errico","year":"2012","unstructured":"Errico A, Costanzo V. Mechanisms of replication fork protection: a safeguard for genome stability. Crit Rev Biochem Mol Biol. 2012;47:222\u201335. https:\/\/doi.org\/10.3109\/10409238.2012.655374.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"1592_CR15","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3109\/07420528.2011.615182.","volume":"28","author":"G Mazzoccoli","year":"2011","unstructured":"Mazzoccoli G, Panza A, Valvano MR, Palumbo O, Carella M, Pazienza V, et al. Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients. Chronobiol Int. 2011;28:841\u201351. https:\/\/doi.org\/10.3109\/07420528.2011.615182.","journal-title":"Chronobiol Int"},{"key":"1592_CR16","doi-asserted-by":"publisher","first-page":"1607455","DOI":"10.1080\/23723556.2019.1607455.","volume":"6","author":"P Pasero","year":"2019","unstructured":"Pasero P, Tourriere H. Overexpression of the Fork Protection Complex: a strategy to tolerate oncogene-induced replication stress in cancer cells. Mol Cell Oncol. 2019;6:1607455 https:\/\/doi.org\/10.1080\/23723556.2019.1607455.","journal-title":"Mol Cell Oncol"},{"key":"1592_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08886-8.","volume":"10","author":"JN Bianco","year":"2019","unstructured":"Bianco JN, Bergoglio V, Lin YL, Pillaire MJ, Schmitz AL, Gilhodes J, et al. Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner. Nat Commun. 2019;10:910 https:\/\/doi.org\/10.1038\/s41467-019-08886-8.","journal-title":"Nat Commun"},{"key":"1592_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00280-015-2901-x.","volume":"77","author":"P Perego","year":"2016","unstructured":"Perego P, Robert J. Oxaliplatin in the era of personalized medicine: from mechanistic studies to clinical efficacy. Cancer Chemother Pharmacol. 2016;77:5\u201318. https:\/\/doi.org\/10.1007\/s00280-015-2901-x.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1592_CR19","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nrc1977.","volume":"6","author":"Y Pommier","year":"2006","unstructured":"Pommier Y. Topoisomerase I inhibitors: camptothecins and beyond. Nat Rev Cancer. 2006;6:789\u2013802. https:\/\/doi.org\/10.1038\/nrc1977.","journal-title":"Nat Rev Cancer"},{"key":"1592_CR20","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1083\/jcb.201406099.","volume":"208","author":"R Zellweger","year":"2015","unstructured":"Zellweger R, Dalcher D, Mutreja K, Berti M, Schmid JA, Herrador R, et al. Rad51-mediated replication fork reversal is a global response to genotoxic treatments in human cells. J Cell Biol. 2015;208:563\u201379. https:\/\/doi.org\/10.1083\/jcb.201406099.","journal-title":"J Cell Biol"},{"key":"1592_CR21","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1158\/1078-0432.CCR-18-1221","volume":"25","author":"AR Parikh","year":"2019","unstructured":"Parikh AR, Lee FC, Yau L, Koh H, Knost J, Mitchell EP, et al. MAVERICC, a randomized, biomarker-stratified, phase II study of mFOLFOX6-bevacizumab versus FOLFIRI-bevacizumab as first-line chemotherapy in metastatic colorectal cancer. Clin Cancer Res. 2019;25:2988\u201395. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1221","journal-title":"Clin Cancer Res"},{"key":"1592_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/s0079-6603(06)81005-6","volume":"81","author":"Y Pommier","year":"2006","unstructured":"Pommier Y, Barcelo JM, Rao VA, Sordet O, Jobson AG, Thibaut L, et al. Repair Topoisomerase I-Mediated DNA Damage. Prog Nucleic Acid Res Mol Biol.2006;81:179\u2013229. https:\/\/doi.org\/10.1016\/s0079-6603(06)81005-6.","journal-title":"Prog Nucleic Acid Res Mol Biol."},{"key":"1592_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/(SICI)1097-0061(19990115)15:1<35::AID-YEA340>3.0.CO;2-R","volume":"15","author":"H Park","year":"1999","unstructured":"Park H, Sternglanz R. Identification and characterization of the genes for two topoisomerase I-interacting proteins from Saccharomyces cerevisiae. Yeast. 1999;15:35\u201341. 10.1002\/(SICI)1097-0061(19990115)15:1<35::AID-YEA340>3.0.CO;2-R.","journal-title":"Yeast"},{"key":"1592_CR24","doi-asserted-by":"publisher","first-page":"11374","DOI":"10.1074\/jbc.M113.531707.","volume":"289","author":"Y Hosono","year":"2014","unstructured":"Hosono Y, Abe T, Higuchi M, Kajii K, Sakuraba S, Tada S, et al. Tipin functions in the protection against topoisomerase I inhibitor. J Biol Chem. 2014;289:11374\u201384. https:\/\/doi.org\/10.1074\/jbc.M113.531707.","journal-title":"J Biol Chem"},{"key":"1592_CR25","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/s1470-2045(01)00454-5.","volume":"2","author":"PJ McHugh","year":"2001","unstructured":"McHugh PJ, Spanswick VJ, Hartley JA. Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance. Lancet Oncol. 2001;2:483\u201390. https:\/\/doi.org\/10.1016\/s1470-2045(01)00454-5.","journal-title":"Lancet Oncol"},{"key":"1592_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0027-5107(01)00142-7","volume":"478","author":"M Kartalou","year":"2001","unstructured":"Kartalou M, Essigmann JM. Recognition of cisplatin adducts by cellular proteins. Mutat Res. 2001;478:1\u201321. https:\/\/doi.org\/10.1016\/s0027-5107(01)00142-7","journal-title":"Mutat Res"},{"key":"1592_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s41021-016-0037-9.","volume":"38","author":"S Hashimoto","year":"2016","unstructured":"Hashimoto S, Anai H, Hanada K. Mechanisms of interstrand DNA crosslink repair and human disorders. Genes Environ. 2016;38:9 https:\/\/doi.org\/10.1186\/s41021-016-0037-9.","journal-title":"Genes Environ."},{"key":"1592_CR28","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrc3088.","volume":"11","author":"AJ Deans","year":"2011","unstructured":"Deans AJ, West SC. DNA interstrand crosslink repair and cancer. Nat Rev Cancer. 2011;11:467\u201380. https:\/\/doi.org\/10.1038\/nrc3088.","journal-title":"Nat Rev Cancer"},{"key":"1592_CR29","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.molcel.2009.08.014.","volume":"35","author":"M Ben-Yehoyada","year":"2009","unstructured":"Ben-Yehoyada M, Wang LC, Kozekov ID, Rizzo CJ, Gottesman ME, Gautier J. Checkpoint signaling from a single DNA interstrand crosslink. Mol Cell. 2009;35:704\u201315. https:\/\/doi.org\/10.1016\/j.molcel.2009.08.014.","journal-title":"Mol Cell"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01592-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01592-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01592-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T02:11:29Z","timestamp":1641348689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01592-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,23]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,1]]}},"alternative-id":["1592"],"URL":"https:\/\/doi.org\/10.1038\/s41416-021-01592-7","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,23]]},"assertion":[{"value":"28 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All patients provided informed consent for molecular research prior to study enrollment. The study protocol was approved by the Institutional Review Boards of each participating institution and was conducted in accordance with the tenets of the Declaration of Helsinki, as well as the Good Clinical Practice and REMARK guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}